Syneron Medical Ltd. (NASDAQ:
ELOS) today announced that its Board of Directors has terminated the shareholder rights plan, effective May 31, 2011.
The shareholder rights plan was adopted on November 11, 2008 after a decline in the market price of Syneron's common stock to ensure that all Syneron shareholders would be treated fairly in the event of any unsolicited takeover of the company.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Posted In:
